New generation VMAT2 inhibitors induced parkinsonism

• Drug induced parkinsonism caused by valbenazine and deutetrabenazine. • Possible side effects of VMAT-2 inhibitors. • Valbenazine and deutetrabenazine can unmask underlying Parkinson’s Disease.

Detalles Bibliográficos
Autores principales: Vasireddy, Rani Priyanka, Sokola, Brent, Guduru, Zain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Cor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298827/
https://www.ncbi.nlm.nih.gov/pubmed/34316656
http://dx.doi.org/10.1016/j.prdoa.2020.100078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298827/
https://www.ncbi.nlm.nih.gov/pubmed/34316656
http://dx.doi.org/10.1016/j.prdoa.2020.100078

Ejemplares similares